Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Estradiol affects extracellular leptin:adiponectin ratio in human breast tissue in vivo.

Morad V, Abrahamsson A, Dabrosin C.

J Clin Endocrinol Metab. 2014 Sep;99(9):3460-7. doi: 10.1210/jc.2014-1129. Erratum in: J Clin Endocrinol Metab. 2014 Sep;99(9):3468.

PMID:
24796929
2.
3.

Correlation between estrogens and serum adipocytokines in premenopausal and postmenopausal women.

Hong SC, Yoo SW, Cho GJ, Kim T, Hur JY, Park YK, Lee KW, Kim SH.

Menopause. 2007 Sep-Oct;14(5):835-40.

PMID:
17667144
4.

The serum estradiol concentration is the main determinant of the estradiol concentration in normal breast tissue.

Depypere HT, Bolca S, Bracke M, Delanghe J, Comhaire F, Blondeel P.

Maturitas. 2015 May;81(1):42-5. doi: 10.1016/j.maturitas.2015.01.014.

PMID:
25721699
5.

Estradiol, tamoxifen, and flaxseed alter IL-1β and IL-1Ra levels in normal human breast tissue in vivo.

Abrahamsson A, Morad V, Saarinen NM, Dabrosin C.

J Clin Endocrinol Metab. 2012 Nov;97(11):E2044-54. doi: 10.1210/jc.2012-2288.

PMID:
22930784
6.

Targeting the adiponectin:leptin ratio for postmenopausal breast cancer prevention.

Cleary MP, Ray A, Rogozina OP, Dogan S, Grossmann ME.

Front Biosci (Schol Ed). 2009 Jun 1;1:329-57. Review.

PMID:
19482706
7.

Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).

Beattie MS, Costantino JP, Cummings SR, Wickerham DL, Vogel VG, Dowsett M, Folkerd EJ, Willett WC, Wolmark N, Hankinson SE.

J Natl Cancer Inst. 2006 Jan 18;98(2):110-5.

PMID:
16418513
8.

Adipokines and Vascular Endothelial Growth Factor in Normal Human Breast Tissue in Vivo - Correlations and Attenuation by Dietary Flaxseed.

Morad V, Abrahamsson A, Kjölhede P, Dabrosin C.

J Mammary Gland Biol Neoplasia. 2016 Jun;21(1-2):69-76. doi: 10.1007/s10911-016-9352-9.

9.

Prognostic effect of circulating adiponectin in a randomized 2 x 2 trial of low-dose tamoxifen and fenretinide in premenopausal women at risk for breast cancer.

Macis D, Gandini S, Guerrieri-Gonzaga A, Johansson H, Magni P, Ruscica M, Lazzeroni M, Serrano D, Cazzaniga M, Mora S, Feroce I, Pizzamiglio M, Sandri MT, Gulisano M, Bonanni B, Decensi A.

J Clin Oncol. 2012 Jan 10;30(2):151-7. doi: 10.1200/JCO.2011.35.2237.

10.

Breast ductal lavage for assessment of breast cancer biomarkers.

Chatterton RT Jr, Parker NP, Habe-Evans M, Bryk M, Scholtens DM, Khan SA.

Horm Cancer. 2010 Aug;1(4):197-204. doi: 10.1007/s12672-010-0021-y.

11.

Decreased secretion of Cathepsin D in breast cancer in vivo by tamoxifen: mediated by the mannose-6-phosphate/IGF-II receptor?

Dabrosin C, Johansson AC, Ollinger K.

Breast Cancer Res Treat. 2004 Jun;85(3):229-38.

PMID:
15111761
12.

Antitumor activity of chemoendocrine therapy in premenopausal and postmenopausal models with human breast cancer xenografts.

Kataoka M, Yamaguchi Y, Moriya Y, Sawada N, Yasuno H, Kondoh K, Evans DB, Mori K, Hayashi S.

Oncol Rep. 2012 Feb;27(2):303-10. doi: 10.3892/or.2011.1541.

PMID:
22076074
13.

Combined treatment with buserelin and tamoxifen in premenopausal metastatic breast cancer: a randomized study.

Klijn JG, Beex LV, Mauriac L, van Zijl JA, Veyret C, Wildiers J, Jassem J, Piccart M, Burghouts J, Becquart D, Seynaeve C, Mignolet F, Duchateau L.

J Natl Cancer Inst. 2000 Jun 7;92(11):903-11.

PMID:
10841825
14.

Effects of tamoxifen on the serum leptin level in patients with breast cancer.

Ozet A, Arpaci F, Yilmaz MI, Ayta H, Ozturk B, Komurcu S, Yavuz AA, Tezcan Y, Acikel C.

Jpn J Clin Oncol. 2001 Sep;31(9):424-7.

PMID:
11689595
15.

Effect of obesity on breast cancer development.

Cleary MP, Grossmann ME, Ray A.

Vet Pathol. 2010 Mar;47(2):202-13. doi: 10.1177/0300985809357753. Review.

PMID:
20124008
16.
17.

In vivo measurement of tumor estradiol and vascular endothelial growth factor in breast cancer patients.

Garvin S, Dabrosin C.

BMC Cancer. 2008 Mar 18;8:73. doi: 10.1186/1471-2407-8-73.

18.

Tamoxifen, flaxseed, and the lignan enterolactone increase stroma- and cancer cell-derived IL-1Ra and decrease tumor angiogenesis in estrogen-dependent breast cancer.

Lindahl G, Saarinen N, Abrahamsson A, Dabrosin C.

Cancer Res. 2011 Jan 1;71(1):51-60. doi: 10.1158/0008-5472.CAN-10-2289.

19.

Leptin and adiponectin: emerging therapeutic targets in breast cancer.

Surmacz E.

J Mammary Gland Biol Neoplasia. 2013 Dec;18(3-4):321-32. doi: 10.1007/s10911-013-9302-8. Review.

PMID:
24136336
20.

A pure antiestrogen, ICI 182,780, stimulates the growth of tamoxifen-resistant KPL-1 human breast cancer cells in vivo but not in vitro.

Kurebayashi J, Otsuki T, Yamamoto S, Kurosumi M, Nakata T, Akinaga S, Sonoo H.

Oncology. 1998 Dec;55 Suppl 1:23-34.

PMID:
9852399
Items per page

Supplemental Content

Support Center